US Capital Global Securities Announces $30MM Investment Opportunity in Next-Generation Tendon Repair Technology

Explore an exclusive investment opportunity in CoNextions Medical, a pioneering medical device company specializing in innovative solutions for tendon repair.

SAN FRANCISCO, AUGUST 2024 – US Capital Global Securities LLC, an SEC-registered affiliate of renowned global financial group US Capital Global, is pleased to present eligible investors with a unique investment opportunity to participate in an investment round of up to $30 million for CoNextions Medical (“CoNextions” or the “Company”).

Based in Salt Lake City, UT, CoNextions specializes in developing innovative tendon repair solutions that surpass traditional suture methods. Their flagship products, the CoNextions TR® Tendon Repair System and Coronet® Soft Tissue Fixation System, provide enhanced strength, faster recovery, and reduced complications for tendon-to-tendon and tendon-to-bone attachments.

“We are thrilled to see our CoNextions TR® and Coronet® systems gaining traction in the market,” said Daniel Gruppo, President and CEO of CoNextions, who has 25 years of experience in the medical device industry. “The TR® device has demonstrated strong commercial performance with a high retention percentage. With FDA clearances and robust market adoption and demand, CoNextions is well-positioned for significant growth, making this an exciting moment for potential investors to join us in transforming patient care.”

“CoNextions’ innovative approach to tendon repair addresses a critical need in the medical field, providing more reliable and efficient solutions for patients and healthcare providers alike,” stated Charles Towle, CEO of US Capital Global Securities LLC. “We believe that the Company’s impressive sales growth and strong market adoption signal a promising future, and we are eager to support its continued success through this round of financing. Eligible investors now have a unique opportunity to participate in CoNextions’ $30 million convertible note offering.”

About CoNextions Medical

Founded in 2011 and based in Salt Lake City, UT, CoNextions Medical specializes in developing advanced tendon repair solutions that outperform traditional suture methods. Their flagship products, the TR® and Coronet® systems, offer enhanced strength, faster recovery, and reduced complications for tendon-to-tendon and tendon-to-bone attachments. With FDA clearances and a proven track record of commercial success, CoNextions is committed to improving patient outcomes and advancing medical innovation. To learn more, visit www.conextionsmed.com.

About US Capital Global

US Capital Global Securities LLC (“USCGS”) serves as the FINRA-member broker-dealer division of US Capital Global, specializing in facilitating growth-stage investments. Since 1998, US Capital Global has been dedicated to providing lower middle market businesses and investors with sophisticated investment opportunities. For further details about US Capital Global Securities or this investment opportunity, contact Pankaj Vashisth, Managing Director of Capital Markets and Partner, at pv@uscapital.com or call +1 415-999-0310.

Disclaimer: USCGS or its affiliates may provide advice to, be compensated by, have other business relationships with, or may from time to time acquire, hold, or sell a position in the securities of the issuers mentioned herein. Any offer or solicitation shall be made only pursuant to the confidential private placement memorandum. View USCGS’ Form CRS at www.uscapglobalsecurities.com/crs.html.